当前位置: X-MOL 学术J. Hypertens. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effects of enhanced versus reduced vasodilating treatment on brachial and central blood pressure in patients with chronic kidney disease: a randomized controlled trial.
Journal of Hypertension ( IF 3.3 ) Pub Date : 2021-07-23 , DOI: 10.1097/hjh.0000000000002942
Dinah Sherzad Khatir 1 , Rasmus Kirkeskov Carlsen 1 , Per Ivarsen 1 , Bente Jespersen 1 , Michael Pedersen 2 , Kent Lodberg Christensen 3 , Niels Henrik Buus 1, 4
Affiliation  

Blood pressure (BP) control is important in chronic kidney disease (CKD), but a reduction in brachial BP may not mirror changes in central aortic BP (cBP) during antihypertensive medication. We hypothesize that a fall in cBP is better reflected during enhanced vasodilation treatment (EVT) compared with reduced vasodilation treatment (RVT) because of different hemodynamic actions of these interventions.

中文翻译:

增强与减少血管舒张治疗对慢性肾病患者肱动脉和中心血压的影响:一项随机对照试验。

血压 (BP) 控制对于慢性肾脏病 (CKD) 很重要,但肱动脉血压的降低可能并不反映抗高血压药物治疗期间中央主动脉血压 (cBP) 的变化。我们假设,与减少血管舒张治疗 (RVT) 相比,增强血管舒张治疗 (EVT) 期间 cBP 的下降得到更好的反映,因为这些干预措施的血流动力学作用不同。
更新日期:2021-07-23
down
wechat
bug